Trastorno psicótico de novo inducido por levetiracetam: ¿existe un perfil de paciente epiléptico neuroestructural y/o biológicamente más vulnerable a desarrollarlo?

León Ruiz, M; Rodríguez Sarasa, ML; Sanjuán Rodríguez, L; Benito-León, J; Álvarez de Toledo, O; Pérez Nieves, MT; Arce Arce, S.
Neurología (Barc., Ed. impr.) ; 35(9): 684-687, nov.-dic. 2020. ilus
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-198654

Documentos relacionados

  1. Behavioral alterations associated with levetiracetam in pediatric epilepsy.
  2. Polycystic ovarian syndrome in Nigerian women with epilepsy on carbamazepine/levetiracetam monotherapy.
  3. Efficacy and safety of levetiracetam in Japanese epilepsy patients: A retrospective cohort study.
  4. Differences in aggression as psychiatric side effect of levetiracetam and perampanel in patients with epilepsy.
  5. Antiepileptic drug monotherapy for epilepsy in the elderly: A systematic review and network meta-analysis.
  6. Side effects of long-term oral anti-seizure drugs on thyroid hormones in patients with epilepsy: a systematic review and network meta-analysis.
  7. Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks?
  8. Effect of levetiracetam on nocturnal sleep in patients with epilepsy.
  9. Levetiracetam-Associated Obsessive-Compulsive Symptoms in a Preschooler.
  10. Neurodevelopment of babies born to mothers with epilepsy: A prospective observational cohort study.